Additional information
Free Base-112110-48-2
White Powder
NA
ACI-023404
66.1-67.0°C
C24H35ClN2O5
467
2-8°C
Antidiabetic
Pharmaceutical Impurity Standards
(3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
(3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
1H-1-Benzazepine-1-acetic acid, 3-[[3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]-2,3,4,5-tetrahydro-2-oxo-, [S-(R*,R*)]





![3’,5’-O,O-DIPHOSPHORYL SOFOSBUVIR (10 mg) (Isopropyl [(S)-{[(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-2-({[{[1-isopropoxy-1-oxopropan-2-yl]amino}(phenoxy)phosphoryl]oxy}methyl)-4-methyltetrahydrofuran-3-yl]oxy}(phenoxy)phosphoryl]-L-alaninate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)